NUMD Nu-Med Plus, Inc.

NUMD financial statements, revenue, balance sheet, cash flow, and SEC filings

CIK: 1543637 Exchange: OTC SIC: 3841 (Surgical & Medical Instruments & Apparatus)
Showing 3 of 14 annual and 0 of 56 quarterly periods. Full history available with a free account or via API.

▼ Company Profile

Filer Category
Non-accelerated filer<br>Smaller reporting company
Entity Type
Operating
Public Float
$3.24M (Jun 2025)
Industry (SIC)
3841 Surgical & Medical Instruments & Apparatus
Incorporated
UT
Fiscal Year End
December (1231)
Phone
631-403-4337
EIN
453672530
Headquarters
PORT JEFFERSON, NY, 11777
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.

▼ Key Metrics (TTM)

As of Jun 30, 2025
Financials
Revenue
-
Net Income
$-60.83K
Total Assets
-
Total Equity
$-246.69K
Total Debt
-
Free Cash Flow
-
Ratios
Return on Equity
24.7%
Sources and calculation details

Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.

Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.

Annual (FY)
Quarterly 🔒
Chart 🔒
Annual financial statements for Nu-Med Plus, Inc.
Metric FY2025 📄 FY2024 📄 FY2023 📄
Income Statement
REVENUE
OPERATING EXPENSES
SG&A Expense $23.12K $34.32K $27.56K
Operating Income $-48.96K $-63.33K $-120.53K
NON-OPERATING INCOME / EXPENSE
Other Income/Expense $-7.23K $-5.01K $-5.00K
Pretax Income $-56.18K $-68.35K $-125.53K
Net Income $-56.18K $-68.35K $-125.53K
PER SHARE & SUPPLEMENTAL
Diluted EPS $0.00 $0.00 $0.00
Diluted Shares 83.55M 83.55M 81.67M
EBITDA $-48.96K $-63.33K $-120.53K
Depreciation & Amortization $0 $0 $0
Balance Sheet
ASSETS
Cash & Equivalents $661 $2.37K $6.81K
Other Current Assets $7.25K $7.00K $6.65K
Current Assets $7.91K $9.37K $13.46K
Noncurrent Assets $0 $0 $0
Total Assets $7.91K $9.37K $13.46K
LIABILITIES
Accounts Payable $48.20K $43.04K $8.09K
Current Liabilities $279.19K $224.47K $160.21K
Noncurrent Liabilities $0 $0 $0
Total Liabilities $279.19K $224.47K $160.21K
EQUITY
Common Stock $83.55K $83.55K $83.55K
Additional Paid-in Capital $9.59M $9.59M $9.59M
Retained Earnings $-9.95M $-9.89M $-9.82M
Total Equity $-271.28K $-215.10K $-146.75K
Total Liabilities & Equity $7.91K $9.37K $13.46K
SUPPLEMENTAL
Shares Outstanding 83.55M 83.55M 83.55M
Check: A − (L + E + NCI) - - -
Cash Flow Statement
Cash from Operations $-47.98K $-4.43K $-66.39K
Capital Expenditures - - -
Cash from Investing - - -
Cash from Financing $46.27K - -
Free Cash Flow - - -
Beginning Cash (CFS) $2.37K $6.81K -
Net Change in Cash - - -
Effect of FX on Cash - - -
Calculated Ending Cash - - -
Cash per BS $661 $2.37K $6.81K
Cash scope difference (CFS − BS) - - -
Cash per CFS $661 $2.37K $6.81K

Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.

Create Free Account Log In
🔒

Quarterly data and charts require a free account

Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.

▼ Frequently Asked Questions

Is Nu-Med Plus, Inc. profitable?

No. Nu-Med Plus, Inc. reported $-60.83K in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.